Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cellsXuejiao Zhao, Ding Ma, Qinglei Gao et al.|Autophagy|2015Cited by 143
Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivationGuannan Li, Qinglei Gao, Xuejiao Zhao et al.|Signal Transduction and Targeted Therapy|2022Cited by 104
FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancerHui‐Ling Lai, Qinglei Gao, Xuejiao Zhao et al.|Journal of Experimental & Clinical Cancer Research|2018Cited by 38
Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistanceMi Zhou, Yang Yang, Ting Wang et al.|Biochemical and Biophysical Research Communications|2015Cited by 22
Rictor orchestrates β-catenin/FOXO balance by maintaining redox homeostasis during development of ovarian cancerXuejiao Zhao, Yong Fang, Hui‐Ling Lai et al.|Oncogene|2025Cited by 2